These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6890538)

  • 1. A study of 922 bacteriologically positive leprosy cases.
    Koticha KK; Nair PR; Juwatkar PS
    Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):330-4. PubMed ID: 6890538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Dapsone in chemotherapy of leprosy--a comparison of responses to therapy in two cohorts in 1960s and 1970s.
    Reddy BN; Neelan PN
    Indian J Lepr; 1984; 56(4):912-8. PubMed ID: 6398345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial clearance with WHO--recommended multidrug regimen for multibacillary leprosy.
    Kishore BN; Shetty JN
    Indian J Lepr; 1995; 67(3):301-8. PubMed ID: 8576609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological significance of indeterminate leprosy--a hospital based study.
    Raveendranathan O; Nair BK; Sarojini PA
    Indian J Lepr; 1991; 63(1):5-11. PubMed ID: 1919090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate and time distribution of relapses in multibacillary leprosy.
    Kurz XM; Declercq EE; Vellut CM
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):599-606. PubMed ID: 2778367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regularity of dapsone intake by leprosy patients attending urban treatment centre.
    Naik SS; Ganapati R
    Lepr India; 1977 Apr; 49(2):207-15. PubMed ID: 909287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An approach to leprosy work in south Bombay--a preliminary communication.
    Daniel JR; Maniar JK; Ganapati R
    Indian J Lepr; 1984; 56(2):280-91. PubMed ID: 6548498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silent iritis in treated bacillary negative leprosy.
    Thompson K; Job CK
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):306-10. PubMed ID: 8862265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of medical agencies and treatment compliance by urban (Madras) leprosy patients.
    Kumar A; Sivaprasad N; Anbalagan M; Thangavel N; Durgambal K
    Lepr India; 1983 Apr; 55(2):322-32. PubMed ID: 6632787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irregularity of Dapsone intake in infectious leprosy patients attending an urban treatment centre--its magnitude and causes.
    Naik SS
    Lepr India; 1978 Jan; 50(1):45-53. PubMed ID: 651317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
    Jing Z; Zhang R; Zhou D; Chen J
    Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dapsone syndrome--a five year retrospective analysis.
    Kumar RH; Kumar MV; Thappa DM
    Indian J Lepr; 1998; 70(3):271-6. PubMed ID: 9801899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy.
    Kamal R; Dayal R; Katoch VM; Katoch K
    Lepr Rev; 2006 Jun; 77(2):141-6. PubMed ID: 16895070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary trial of intervention levamisole therapy in persistently bacteriologically positive lepromatous leprosy.
    Ramu G; Sengupta U
    Lepr India; 1983 Jan; 55(1):64-7. PubMed ID: 6876762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between regularity in dapsone (DDS) treatment and development of deformity.
    Radhakrishna S; Nair NG
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):425-34. PubMed ID: 3655458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic characteristics of leprosy reactions.
    Scollard DM; Smith T; Bhoopat L; Theetranont C; Rangdaeng S; Morens DM
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):559-67. PubMed ID: 7868954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological shift in leprosy in a rural district of central India following introduction of multi-drug therapy (April 1986 to March 1992 and April 1992 to March 2002).
    Pandey A; Uddin MJ; Patel R
    Lepr Rev; 2005 Jun; 76(2):112-8. PubMed ID: 16038244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the characteristics and causes of relapse amongst leprosy cases in an urban area (Calcutta).
    Saha SP; Das KK
    Indian J Lepr; 1992; 64(2):169-78. PubMed ID: 1607715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.